Alfresa Holdings Corporation (ALFRY)

Market Cap	2.47B -11.1%
Revenue (ttm)	19.52B +4.8%
Net Income	262.55M +52.4%
EPS	1.44 +55.6%
Shares Out	n/a
PE Ratio	9.39
Forward PE	n/a
Dividend	0.44 (3.20%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	13.80
Previous Close	13.80
Day's Range	13.80 - 13.80
52-Week Range	11.39 - 16.81
Beta	-0.17
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,452
• Stock Exchange: OTCMKTS
• Ticker Symbol: ALFRY

Financial Performance

In fiscal year 2026, Alfresa Holdings's revenue was 3.10 trillion, an increase of 4.83% compared to the previous year's 2.96 trillion. Earnings were 41.75 billion, an increase of 52.42%.

Financial numbers in JPY